• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植受者中基于血药浓度峰值(Cmax)的环孢素治疗药物监测:它适用于所有人群吗?

Cyclosporine therapeutic monitoring with Cmax in kidney transplant recipients: does it fit for all populations?

作者信息

El-Agroudy Amgad E, Ismail Amani M, Nassar Mohamed, Ghoneim Mohamed A

机构信息

Urology & Nephrology Center, Mansoura University, Mansoura, Egypt.

出版信息

Exp Clin Transplant. 2008 Dec;6(4):282-6.

PMID:19338490
Abstract

BACKGROUND

We sought to assess whether the single cyclosporine concentration taken 2 hours after administration (C2) is a good parameter to predict a drug's maximal concentration (Cmax) value in Egyptian kidney transplant recipients.

MATERIALS AND METHODS

Fifty stable Egyptian kidney transplant recipients with a previously diagnosed schistosomal infection were compared with 50 Egyptian kidney transplant recipients without a schistosomal infection regarding cyclosporine concentrations at time 0 (trough), and then at 1.5, 2, 2.5, 3, and 3.5 hours after a dose of cyclosporine. We used a linear regression analysis to assess any statistically significant differences between the different cyclosporine time concentrations and drug dosages.

RESULTS

Patients in the schistosomal group had significantly lower C2 levels (511 -/+ 118 nmol/L) compared with those in the nonschistosomal (control) group (669 -/+ 213 nmol/L) (P < .05), whereas the C2.5 level was significantly higher (730 -/+ 215 and 527 -/+ 129 nmol/L, respectively; P < .05). A significant linear regression relation was determined for only C2.5 in the schistosomal group with both morning cyclosporine dose and cyclosporine dose expressed as mg/kg/d (P = .0123, r = .573018).

CONCLUSIONS

Egyptian patients have special characteristics with regard to drug absorption and metabolism, mostly owing to schistosomal infection, and they may need the use of C2.5 to monitor cyclosporine. If confirmed by subsequent, larger studies, our findings may have a significant effect on our understanding and management of cyclosporine immunosuppression in clinical renal transplants with persons of different ethnicities.

摘要

背景

我们试图评估给药2小时后的单一环孢素浓度(C2)是否是预测埃及肾移植受者药物最大浓度(Cmax)值的良好参数。

材料与方法

将50例先前诊断为血吸虫感染的稳定埃及肾移植受者与50例无血吸虫感染的埃及肾移植受者在时间0(谷值)以及给予一剂环孢素后1.5、2、2.5、3和3.5小时的环孢素浓度进行比较。我们使用线性回归分析来评估不同环孢素时间浓度与药物剂量之间的任何统计学显著差异。

结果

血吸虫组患者的C2水平(511±118 nmol/L)显著低于非血吸虫(对照)组(669±213 nmol/L)(P<.05),而C2.5水平显著更高(分别为730±215和527±129 nmol/L;P<.05)。仅在血吸虫组中确定了C2.5与早晨环孢素剂量以及以mg/kg/d表示的环孢素剂量之间存在显著的线性回归关系(P = .0123,r = .573018)。

结论

埃及患者在药物吸收和代谢方面具有特殊特征,主要是由于血吸虫感染,他们可能需要使用C2.5来监测环孢素。如果后续更大规模的研究证实,我们的发现可能会对我们理解和管理不同种族人群临床肾移植中环孢素免疫抑制产生重大影响。

相似文献

1
Cyclosporine therapeutic monitoring with Cmax in kidney transplant recipients: does it fit for all populations?肾移植受者中基于血药浓度峰值(Cmax)的环孢素治疗药物监测:它适用于所有人群吗?
Exp Clin Transplant. 2008 Dec;6(4):282-6.
2
Cyclosporine therapeutic monitoring with C(MAX) in kidney transplant recipients: racial considerations.
Clin Exp Nephrol. 2009 Apr;13(2):156-160. doi: 10.1007/s10157-008-0111-0. Epub 2008 Dec 16.
3
Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose.术前肾移植受者给药后2小时环孢素水平的研究,用于预测术后最佳环孢素剂量。
J Med Assoc Thai. 2006 Aug;89 Suppl 2:S15-20.
4
Comparison of cyclosporine concentrations 2 hours post-dose determined using 3 different methods and trough level in pediatric renal transplantation.小儿肾移植中使用3种不同方法测定给药后2小时环孢素浓度及谷浓度的比较。
Transplant Proc. 2005 Oct;37(8):3354-7. doi: 10.1016/j.transproceed.2005.10.004.
5
Immunosuppressive drug monitoring of sirolimus and cyclosporine in pediatric patients.小儿患者中雷帕霉素和环孢素的免疫抑制药物监测
Clin Biochem. 2004 Jun;37(6):424-8. doi: 10.1016/j.clinbiochem.2004.04.001.
6
C2 monitoring of cyclosporine in stable renal transplant patients results in lower costs and improved renal function.对稳定期肾移植患者进行环孢素的C2监测可降低成本并改善肾功能。
Transplant Proc. 2005 Apr;37(3):1583-5. doi: 10.1016/j.transproceed.2004.09.016.
7
C2 and C0 values for monitoring cyclosporine therapy in stable heart transplant recipients.用于监测稳定期心脏移植受者环孢素治疗的C2和C0值。
Transplant Proc. 2005 Mar;37(2):1355-9. doi: 10.1016/j.transproceed.2005.01.079.
8
Evolution of the absorption profile of cyclosporine A in renal transplant recipients: a longitudinal study of the de novo and maintenance phases.肾移植受者中环孢素A吸收曲线的演变:对起始期和维持期的纵向研究。
Nephrol Dial Transplant. 2006 Jan;21(1):197-202. doi: 10.1093/ndt/gfi113. Epub 2005 Oct 4.
9
C2 monitoring in maintenance renal transplant recipients: is it worthwhile?维持性肾移植受者的C2监测:是否值得?
Transplantation. 2003 Oct 27;76(8):1236-8. doi: 10.1097/01.TP.0000085046.39523.D5.
10
Mycophenolic acid formulation affects cyclosporine pharmacokinetics in stable kidney transplant recipients.霉酚酸制剂对稳定期肾移植受者中环孢素的药代动力学有影响。
Ther Drug Monit. 2006 Oct;28(5):643-9. doi: 10.1097/01.ftd.0000245379.87563.3b.

引用本文的文献

1
Electrolytes Disturbance and Cyclosporine Blood Levels among Kidney Transplant Recipients.肾移植受者的电解质紊乱与环孢素血药浓度
Int J Organ Transplant Med. 2012;3(4):166-75.
2
A review on therapeutic drug monitoring of immunosuppressant drugs.免疫抑制剂治疗药物监测的综述。
Iran J Basic Med Sci. 2011 Nov;14(6):485-98.